Good Week — #6

Hello, friends — welcome back to our cozy corner of good news. This is episode 6, our good‑news roundup for the week of July 26. I’m Emma, and I brought freshly brewed optimism and a seat by the window.

And I’m Jack, bringing the sturdy thermos of facts. Shall we start with something small and human that just makes you smile?

A $1 million smile, actually. The Michigan Lottery said a Powerball ticket bought at a place called Basel Oil in Rogers City matched five of the six numbers. One million dollars on July 25 — that is a grocery‑store errand that suddenly got very interesting.

The jackpot itself rolled over to an estimated $633 million for the next drawing, but this winner didn’t exactly walk away empty‑handed. Also, note the details are solid: location, amount, date, and the match of five numbers. Nice clean story, and a very lucky pit stop for gas.

Imagine pulling in for windshield washer fluid and leaving with early retirement dreams. To whoever you are, we hope you had someone to high‑five that night.

From luck to looking out for each other. Shark Week brought some practical beach wisdom. Wildlife biologist Forrest Galante shared safety tips to reduce the risk of shark encounters, and one simple one stood out: avoid going into the water at dawn and dusk.

That advice is straightforward and evidence‑friendly. Fewer silhouettes in low light, less confusion in the water. The broader point is sensible risk reduction without scaring anyone away from a good swim.

It’s the kind of community knowledge that makes summer nicer — a lifeguard’s whistle in podcast form. And speaking of being seen clearly, there’s new attention on how attention itself is seen: a study from the Duke Center for Girls and Women with ADHD reported that ADHD often manifests differently in females, leading to delayed diagnoses. The research, led by Julia Schechter, found that women are typically diagnosed later than men, raising health risks when care comes too late.

The key words there are “often” and “later.” That’s a health story framed as a fairness story: better recognition means earlier help. No drama, just better questions and better outcomes.

And if you’re listening and thinking, “That sounds like me,” consider this your gentle nudge to talk to someone who can listen in a structured, professional way. A label that fits can be a relief.

Let’s pour a cup of everyday health news, literally. The American Heart Association said up to 400 milligrams of caffeine daily — about five eight‑ounce cups of coffee — does not increase cardiovascular risk and might even lower it.

That’s a scientific statement, so it’s a careful consensus, not a dare. It doesn’t green‑light chugging espresso like it’s a competitive sport, but ordinary coffee drinkers can unclench a little.

Permission to sip granted. And The World Health Organization updated its dementia prevention guidelines. They’ve added air pollution and brain training to the list of risk‑reduction measures, and they emphasized social engagement and mental activity as ways to lower risk. They also highlighted that roughly half of dementia cases could be preventable.

Two items to separate: prevention guidelines are about reducing risk, not guarantees. The addition of air pollution and brain training reflects growing evidence, and the 50 percent figure underscores how much room there is for action at the personal and policy levels.

Finally, a timing tip that could save a life: researchers at Stanford’s Stroke Center and the American Heart Association reported that stroke risk spikes between 6 a.m. and noon in the United States. That window aligns with the body’s early‑day shifts like higher blood pressure.

The takeaway isn’t panic at sunrise — it’s awareness. Know the signs, and don’t wait to call for help if something seems off in those hours, or any hours.

Early coffee, early signs, early action. That’s a morning routine we can get behind.

Now for medical tools that feel like the future arriving early. In the United Kingdom, NICE approved the Endotest saliva test for endometriosis. It looks for microRNA markers linked to the condition, giving clinicians in England and Wales a noninvasive way to aid detection.

That’s a regulator’s green light, which matters. It’s not a cure, it’s a diagnostic aid — but given how long and painful the path to an endometriosis diagnosis can be, a saliva test is a meaningful step toward earlier answers.

And in Cambridge, Massachusetts, the Broad Institute, Boston Children’s Hospital, and the Jackson Laboratory announced a nonprofit Center for Therapeutic Genetics. The focus: developing and sharing gene‑editing treatments for rare genetic disorders.

Treat “nonprofit” and “sharing” as the key words. It suggests a push to widen access and standardize tools rather than hoard them. No miracle claims here — just a practical platform to move rare‑disease therapies forward.

Even measured progress can feel massive when you’re waiting for it. For families living with rare conditions, this is a light switching on.

Speaking of lights switching on — space is sending out some very shiny headlines. NASA and the European Space Agency said they’ve confirmed evidence of liquid water under the ice shells of at least six moons: Mimas, Titan, Europa, Ganymede, Callisto, and Enceladus.

Confirmed evidence of subsurface oceans on those bodies is extraordinary because water is step one on humanity’s “could life ever?” bingo card. We’re not claiming anything about life — just that there’s liquid water, and that alone makes future missions more compelling.

One of those future missions got the go‑ahead: NASA plans to launch the nuclear‑powered Dragonfly rotorcraft to Titan. It’s about a thousand pounds, will fly like a drone between sites, and the mission is budgeted at $3.35 billion over six years.

That’s a medium‑long mission horizon with a clear purpose: hop, scan, sample, repeat. Titan’s chemistry is a playground for curiosity.

And closer to home, a long shift ended well. After 241 days aboard the International Space Station, NASA astronaut Chris Williams and Russian cosmonauts Sergei Kud‑Sverchkov and Sergei Mikaev landed safely in Kazakhstan on July 26, touching down near Dzhezkazgan.

The word “safely” does a lot of work here. Months in orbit, then a precise fall back through the atmosphere and a soft landing in the steppe — it’s still remarkable every time.

Down the launch tower to technology on the move. SpaceX launched the 13th test flight of Starship from Starbase in Texas on July 24, a day later than planned because of weather. The company said it completed extra pre‑flight testing of the Super Heavy booster, the flight succeeded, and it’s now spurring tower‑catch plans.

Weather delay, then a clean outcome is the pattern you want in testing. And the “tower‑catch plans” note is about pushing reusability — ambitious, but we’ll file it as “plans” until hardware meets gravity.

On the software side, Alphabet said its Gemini AI chatbot reached 950 million monthly active users in the second quarter. They also reported quarterly revenue up 24 percent to $119.8 billion. That user count was up from about 750 million earlier.

Those are reported company figures. The increase in users is the headline; the revenue jump frames how much mainstream the tools have become.

And a claim from another corner of the AI world: OpenAI’s Sam Altman said on a podcast recorded in Paris that the AI industry has entered the technological singularity — that AI now exceeds human intelligence and is beyond predictable control.

Label this clearly as a claim. It’s provocative language, not an independently verified milestone. Interesting to debate, but not a settled fact.

We promise not to hand the mic to a mysterious disembodied algorithm for a rebuttal. For now, we’ll stick with people.

Time for sports, where the theme this week is resilience meeting results. Kansas City Chiefs rookies Cyrus Allen and Emmett Johnson said their first training‑camp practice on July 26 was, in their words, grueling — praising head coach Andy Reid and offensive coordinator Eric Bieniemy for the intensity.

That’s rookies endorsing hard coaching, which is not always the headline. It also pairs neatly with another Chiefs note: Patrick Mahomes has been cleared for training camp after ACL and LCL surgery, and he’ll wear a knee brace.

He said he sought advice from Tom Brady and other veterans who came back from similar injuries. That’s the wisdom of the village right there.

In international football, a quick follow‑up to a story we discussed last week. The World Cup final at MetLife Stadium in New Jersey ended 2–1 after extra time, with Spain defeating Argentina. That is the update — result, venue, time frame — clean and complete.

And in cycling, another follow‑up: Tadej Pogacar has won his fifth Tour de France title. Along the way, reports noted he retained the yellow jersey, added stage victories, and widened his overall lead with a win on stage 10.

When the summary says “dominant mountain performances,” that’s not hyperbole — that’s the terrain doing the talking.

Finally, a seismic roster move: LeBron James is joining the Philadelphia 76ers on a two‑year deal. He informed the Lakers he wouldn’t return for the 2026–27 season and entered free agency, with earlier reports mentioning other suitors, but the decision is made.

That’s a confirmed destination with the contract length specified. No need to add numbers — the headline is where he’s headed and for how long.

Culture and big screens — it’s a lively week. Chris Evans told fans at San Diego Comic‑Con that Marvel pitched him at least a dozen story ideas before he agreed to reprise Captain America. Imagine that whiteboard.

That’s quantity and, presumably, quality control. It’s also a reminder that even familiar heroes get stress‑tested before they come back.

Over in Wakanda’s world, director Ryan Coogler announced Black Panther III for December 15, with David Jonsson taking the lead as Toussaint — the grown‑up son of T’Challa introduced in Wakanda Forever.

Firm date, named lead, clear character. That’s unusually concrete for a big‑franchise announcement.

And the box office is buzzing. Christopher Nolan’s three‑hour epic, The Odyssey, has reached $640 million worldwide by its second weekend, after opening on July 16 with a projected global launch north of $200 million.

In the family lane, Toy Story 5 has topped $1 billion worldwide. Two very different audiences, one very consistent theme: people are showing up.

Popcorn, please — and a nap after the three‑hour epic.

World stage, everyday wins. The World Cup held in Mexico and the United States drew record crowds and strong feedback from visitors, with a noticeable boost in interest across the U.S. and praise for Spain’s defense. You love to see a tournament deliver joy and momentum.

Safety has been part of that delivery. The FBI, led by Director Kash Patel, reported a major security operation for the Seattle matches, with about 5,000 personnel deployed and roughly 700 unauthorized drones intercepted. They also put lasting counter‑drone measures in place and ran extensive background checks for staff.

That’s a lot of logistics behind thousands of cheers. On the tech‑defense front, Lockheed Martin unveiled a lower‑cost Patriot interceptor — the PAC‑3 Adapted Capability Effector — in England. It’s designed to be fully compatible with existing systems and cost less than half of a PAC‑3 MSE unit.

Lower unit cost matters for sustained defense budgets, and compatibility lowers friction. It’s an incremental, useful improvement.

And an innovation story with a different arc: Ukrainian officials and NATO representatives said Ukraine has shifted from primarily receiving aid to developing its own defense technologies and sharing lessons with allies.

Frame it as capability building: moving from dependency to contribution. That’s a strategic positive.

Meanwhile in civics, Italy’s Constitutional Court referred a contested citizenship‑by‑descent law to the European Court of Justice, suspending its earlier endorsement. The court said the measure may conflict with EU rules on free movement and non‑discrimination.

That’s the process working: pause, ask the top court, and get legal clarity before proceeding. Not splashy, but good governance often isn’t.

Let’s land with some money moves and momentum. A 67‑year‑old retiree shared a plan — highlighted by analysts — to target up to $4,800 in monthly dividend income using three holdings: the Schwab U.S. Dividend Equity ETF, Realty Income, and the JPMorgan Nasdaq Equity Premium Income ETF. It’s not a guarantee, but it’s a tangible example of planning with a purpose.

Right — a case study, not personal financial advice. The analysis also discussed what it would take to reach that target; specifics vary by portfolio and market conditions.

On the corporate side, there’s a turnaround you can feel from space: General Electric’s Larry Culp completed a multi‑billion‑dollar turnaround and a three‑way split of the company, with aggressive debt reduction that substantially lowered leverage.

Those are Fortune‑reported milestones. Debt down, structure simplified — the boring plumbing that investors quietly applaud.

And in biotech, Eli Lilly acquired AtaiBeckley for $2.8 billion in cash, with up to $1 billion in potential milestone payments tied to development goals. Investor Christian Angermayer is set to receive an estimated $360 million from the deal.

That’s a bet on psychedelic‑medicine development moving from promise to product. The milestone component makes clear it’s progress‑contingent.

From dividends to daring science, there’s a real sense this week of people and institutions trying to build things that last.

And documenting the steps, not just the finish lines. Good week indeed.

If you want more of this calm corner, come find us at factslane.com and in the apps — we’re on the App Store and Google Play. Try the Zen mode there: it’s all positive news, just like this show, when you need a little breather.

And if your curiosity is still caffeinated, check out our sister roundups — Science Week and Tech Week — for deeper dives, minus the hype.

Thank you for spending part of your Sunday with us. Take good care, have a great week ahead, and we’ll see you next week.

Be well, stay curious, and until next time.